Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
Recruiting · NCT06397963 · Registry updated 2026-01-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours | Solid Tumor, Adult | Recruiting | Not applicable | 2026-01-26 | NCT06397963 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Arion Cancer Center | 1 |
| Beijing GoBroad Hospital | 42 |
| Grit Biotechnology | 19 |
| The Affiliated Hospital of Xuzhou Medical University | 68 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Arion Cancer Center | Beijing | China | 1 |
| Beijing GoBroad Hospital | Beijing | China | 6 |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou | China | 30 |